Tokyo-to, Japan

Shinpei Kidokoro


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Shinpei Kidokoro

Introduction

Shinpei Kidokoro, an accomplished inventor based in Tokyo-to, Japan, has made significant strides in the field of pharmaceutical innovations. With one patent to his name, his work focuses on novel compounds with promising therapeutic applications.

Latest Patents

Shinpei Kidokoro's notable patent is titled "Novel compounds exhibiting a vasodilating activity and inhibitory activity for platelet aggregation." This patent describes unique compounds represented by a complex formula that demonstrates effective vasodilating activity and inhibits platelet aggregation. Such compounds are crucial for developing treatments aimed at conditions like angina pectoris, hypertension, and thrombosis.

Career Highlights

Throughout his career, Kidokoro has focused on the intersection of chemistry and medicine, aiming to create innovative solutions for pressing health concerns. His dedication to research and development in pharmacology underscores his commitment to enhancing patient outcomes through novel therapeutic agents.

Collaborations

Shinpei Kidokoro has collaborated with esteemed colleagues, including Hiroyoshi Hidaka and Tomohiko Ishikawa. Their joint efforts reflect a synergy of expertise and innovation in their research pursuits, contributing to the advancement of their field.

Conclusion

In conclusion, Shinpei Kidokoro stands out as a prominent inventor whose work has the potential to impact the medical landscape significantly. With his patented compounds, he is paving the way for new treatments that could benefit countless patients suffering from cardiovascular-related ailments. His collaborations with fellow researchers further amplify his contributions to pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…